These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9415315)

  • 21. Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.
    Mühlebach MD; Schmitt I; Steidl S; Stitz J; Schweizer M; Blankenstein T; Cichutek K; Uckert W
    J Mol Med (Berl); 2003 Dec; 81(12):801-10. PubMed ID: 14576928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration.
    Porcellini S; Alberici L; Gubinelli F; Lupo R; Olgiati C; Rizzardi GP; Bovolenta C
    Blood; 2009 Apr; 113(15):3443-52. PubMed ID: 19211937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
    Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
    Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of the establishment of HIV-1 viral interference and comprehensive analysis of the contribution of viral genes.
    Remion A; Delord M; Hance AJ; Saragosti S; Mammano F
    Virology; 2016 Jan; 487():59-67. PubMed ID: 26499042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.
    Okamoto M; Chono H; Kawano Y; Saito N; Tsuda H; Inoue K; Kato I; Mineno J; Baba M
    Hum Gene Ther Methods; 2013 Apr; 24(2):94-103. PubMed ID: 23442049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.
    Klebba C; Ottmann OG; Scherr M; Pape M; Engels JW; Grez M; Hoelzer D; Klein SA
    Gene Ther; 2000 Mar; 7(5):408-16. PubMed ID: 10694823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
    Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
    Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE; Ramezani A; Li X; Joshi S
    Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical characterization of an anti-tat ribozyme for therapeutic application.
    Wang L; Witherington C; King A; Gerlach WL; Carr A; Penny R; Cooper D; Symonds G; Sun LQ
    Hum Gene Ther; 1998 Jun; 9(9):1283-91. PubMed ID: 9650613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.
    VandenDriessche T; Chuah MK; Chiang L; Chang HK; Ensoli B; Morgan RA
    J Virol; 1995 Jul; 69(7):4045-52. PubMed ID: 7769662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retroviral superinfection resistance.
    Nethe M; Berkhout B; van der Kuyl AC
    Retrovirology; 2005 Aug; 2():52. PubMed ID: 16107223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells.
    Zila V; Müller TG; Laketa V; Müller B; Kräusslich HG
    mBio; 2019 Nov; 10(6):. PubMed ID: 31690677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
    Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
    Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
    Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
    Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments.
    Ho WZ; Lai JP; Bouhamdan M; Duan L; Pomerantz RJ; Starr SE
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1573-80. PubMed ID: 9840290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1.
    Fernández Larrosa PN; Ceballos A; Andreani G; Marquina S; Martínez Peralta L; Rabinovich RD
    Arch Virol; 2006 Apr; 151(4):651-62. PubMed ID: 16362643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.